| 51 |
11094056 | Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization. | 2001 Feb 16 |
6 |
| 52 |
11212259 | Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis. | 2001 Jan 15 |
6 |
| 53 |
11454885 | Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients. | 2001 Jul 15 |
3 |
| 54 |
10786679 | Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. | 2000 Apr 15 |
6 |
| 55 |
10914720 | p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. | 2000 Jul |
1 |
| 56 |
11106256 | Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice. | 2000 Nov |
2 |
| 57 |
10661763 | Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance. | 1999 Dec |
1 |
| 58 |
9440732 | p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. | 1998 Jan |
6 |
| 59 |
9553810 | Random nuclear p53 overexpression pattern in tamoxifen-mediated endometrial carcinoma. | 1998 Apr |
2 |
| 60 |
9751262 | p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells. | 1998 Aug 14 |
3 |
| 61 |
9891537 | A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas. | 1998 Nov-Dec |
3 |
| 62 |
9164202 | bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. | 1997 May |
1 |
| 63 |
9233778 | Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. | 1997 Jul 3 |
1 |
| 64 |
9285694 | Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. | 1997 Aug 18 |
2 |
| 65 |
9332764 | A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer. | 1997 Oct |
3 |
| 66 |
8622078 | p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. | 1996 May |
1 |
| 67 |
9042218 | Genomic effects of tamoxifen. | 1996 Nov-Dec |
1 |
| 68 |
9816318 | Alteration of p53 damage response by tamoxifen treatment. | 1996 Sep |
1 |
| 69 |
9815913 | p53 mutation and tamoxifen resistance in breast cancer. | 1995 Oct |
2 |
| 70 |
7907850 | Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma. | 1993 Nov-Dec |
1 |